Literature DB >> 23036705

Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes.

Franco Gabrielli1, Sergio Tofanelli.   

Abstract

Human DHRS2 and DHRS4 genes code for similar NADP-dependent short-chain carbonyl-reductase enzymes having different substrate specificity. Human DHRS2 and DHRS4 enzymes share several common sequence motives including residues responsible for coenzyme binding as well as for the intimate catalytic oxido-reductase mechanism, while their substrate-binding sequences have very low similarity. We found that DHRS2 and DHRS4 genes are syntenic outparalogues originated from a duplication of the DHRS4 gene that took place before the formation of the mammalian clade. DHRS2 gene evolved more rapidly and underwent positive selection on more sites than the DHRS4 gene. DHRS2 sites under positive selection were mainly located on the enzyme active site thus showing that substrate specificity drove the divergence from the DHRS4 enzyme. Rapid divergent evolution brought the human DHRS2 enzyme to have subcellular localization, synthesis regulation and specialized cellular functions very different from those of the human DHRS4 enzyme.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036705     DOI: 10.1016/j.gene.2012.09.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Genetic variation predicts serum lycopene concentrations in a multiethnic population of postmenopausal women.

Authors:  Niha Zubair; Charles Kooperberg; Jingmin Liu; Chongzhi Di; Ulrike Peters; Marian L Neuhouser
Journal:  J Nutr       Date:  2014-12-03       Impact factor: 4.798

2.  Expanding the Halohydrin Dehalogenase Enzyme Family: Identification of Novel Enzymes by Database Mining.

Authors:  Marcus Schallmey; Julia Koopmeiners; Elizabeth Wells; Rainer Wardenga; Anett Schallmey
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

3.  Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.

Authors:  Jiang-Yi He; Ping Han; Yu Zhang; Yong-Dong Liu; Shi-Jian Song; Guo-Kai Feng; Yu An; Ai-Jun Zhou; Hong-Bo Wang; Li Yuan; Zhi-Rui Lin; Tian-Liang Xia; Man-Zhi Li; Yan-Min Liu; Xiao-Ming Huang; Hua Zhang; Qian Zhong
Journal:  J Mol Med (Berl)       Date:  2018-01-11       Impact factor: 4.599

4.  Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.

Authors:  Xiaofeng Dai; Yang Li; Zhonghu Bai; Xu-Qing Tang
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

5.  Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster.

Authors:  Yingying Yang; Zhongjing Su; Xuhong Song; Bin Liang; Fanxing Zeng; Xiaolan Chang; Dongyang Huang
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

6.  Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses.

Authors:  Michelle E Penney; Patrick S Parfrey; Sevtap Savas; Yildiz E Yilmaz
Journal:  Biomark Res       Date:  2018-06-13

7.  Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.

Authors:  Ji-Min Li; Guan-Min Jiang; Liang Zhao; Fang Yang; Wei-Qi Yuan; Hao Wang; Yi-Qin Luo
Journal:  Oncol Rep       Date:  2019-08-22       Impact factor: 3.906

8.  Classification of glioma based on prognostic alternative splicing.

Authors:  Yaomin Li; Zhonglu Ren; Yuping Peng; Kaishu Li; Xiran Wang; Guanglong Huang; Songtao Qi; Yawei Liu
Journal:  BMC Med Genomics       Date:  2019-11-15       Impact factor: 3.063

9.  DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.

Authors:  Y Zhou; L Wang; X Ban; T Zeng; Y Zhu; M Li; X-Y Guan; Y Li
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

10.  Familial Alzheimer's Disease and Recessive Modifiers.

Authors:  Jorge I Vélez; Francisco Lopera; Claudia T Silva; Andrés Villegas; Lady G Espinosa; Oscar M Vidal; Claudio A Mastronardi; Mauricio Arcos-Burgos
Journal:  Mol Neurobiol       Date:  2019-10-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.